Brexit – UK IVDs Favor Bremain By 2:1 But Don’t Knows Still High
This article was originally published in Clinica
Executive Summary
Six weeks to the UK’s EU referendum, and the gloves are really starting come off in both the Leave and Britain Stronger in Europe camps, now that the UK parliamentary, council and mayoral elections (May 5) are out of the way.
You may also be interested in...
IVD UK Spring Meeting: Diagnostics Get New Market Access Tools – But At A Price
First of two articles covering discussion at the spring 2017 meeting of the British In Vitro Diagnostics Association: The UK IVD companies are soon to get new tools designed to make market access for innovations easier and more predictable. This is welcome news, given the backdrop of Brexit and the costly route to compliance to the new EU IVD Regulation compliance.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.